Skip to main content
Global Site Support
Follow us
✕
Company
Mission
About IXICO
IXI™ Platform
The Power of Neuroimaging
Customers
Partnerships
Leadership Team
Careers
Recruitment privacy notice
IXI™ Platform
AI-Driven Insights
Platform Features
Platform Evolution
Services
Imaging Biomarkers
Radiological reads
Volumetric MRI
PET & SPECT
Advanced MRI
Trial Management
Data Analytics
Post-Marketing Surveillance
Consultancy
Therapeutic Expertise
Alzheimer's Disease (AD)
Huntington's Disease (HD)
Parkinson's Disease (PD)
Multiple Sclerosis (MS)
Other Rare Neurological Diseases
News & Resources
News
Scientific Publications
Webinars
Downloads
Blog
Investors
Share Price
Governance
AIM Rule 26
Our Board
Oversight
Contacts & Advisers
Investor Resources
Company Documents
Financial Calendar
Investor Presentations
Investor Videos
RNS News
Regulatory Email Alert
Shareholder Info
Contact us
Submit RFP
Contact Us
Global Site Support
\
News & Resources
News & Resources
Sources
News
Scientific Publications
Webinars
Downloads
Blog
Sources
News
Scientific Publications
Webinars
Downloads
Blog
25 Feb 26
publications
Further validation of IXI technology platform automation capabilities
Read more
17 Feb 26
blog
Advancing a Multimodal Future for Alzheimer’s Disease Diagnosis
Read more
17 Feb 26
blog
Multi-biomarker assessment to better understand clinical dementia symptoms
Read more
12 Feb 26
news
c.£1.5 million contract extension on global Phase 2 clinical trial
Read more
5 Feb 26
news
IXICO appoints Chief Commercial Officer to accelerate business development activity
Read more
3 Feb 26
publications
Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology
Read more
28 Jan 26
publications
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease
Read more
14 Jan 26
publications
Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding
Read more
13 Jan 26
blog
Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics
Read more
8 Dec 25
news
Financial Results for year ended 30 September 2025 and Notice of AGM
Read more
4 Dec 25
publications
AI-Driven Recruitment for AD Clinical Trials A Pilot Analysis on the A4 Study Dataset
Read more
1 Dec 25
news
IXICO strengthens Scientific Advisory Board with two prominent global Alzheimer’s Disease experts
Read more
1
2
3
4
5
...
12
Prev
Next
1 - 12 of 133 results
Ixico News on Proactive
IXICO boosts pipeline with Huntington’s Disease trial contract
February 12th 2026 07:49 AM
IXICO eyes accelerated business development activity as it hires new CCO
February 5th 2026 08:11 AM
IXICO advances AI neuroimaging to lead CNS research
December 29th 2025 11:00 AM
IXICO jumps as broker hails ‘pivotal year’ and sharp forecast upgrades
December 9th 2025 12:15 PM
IXICO CEO on 2025 results & 2026 growth outlook
December 9th 2025 09:55 AM
IXICO shares rise 4% as company gives an upbeat assessment of prospects
December 9th 2025 09:15 AM
IXICO upbeat on 2026 as contract wins swell order book
December 9th 2025 07:25 AM
IXICO tipped to keep growing, broker eyes upcoming catalysts
December 2nd 2025 15:53 PM
IXICO adds two leading dementia specialists to advisory board
December 1st 2025 07:25 AM
IXICO signs £3.5m Huntington's trial contract - ICYMI
November 22nd 2025 09:00 AM
IXICO secures £3.5M phase 3 trial contract as CEO highlights Huntington’s research momentum
November 17th 2025 19:35 PM
IXICO climbs 5% on £3.5 million Huntington’s trial win
November 17th 2025 11:30 AM
IXICO lands £3.5m contract for global Huntington’s trial
November 17th 2025 07:07 AM
IXICO CEO on biomarker strategy and growth - ICYMI
October 18th 2025 05:45 AM
IXICO CEO on strong 2025 performance, 2026 priorities
October 16th 2025 07:35 AM
Updated: 0 minute 0 seconds ago
Sign-up to the latest from IXICO
